Steven M. Albelda is a board-certified pulmonary disease, critical care and internal medicine physician designing new strategies for mesothelioma treatment based on the rapidly evolving disciplines of molecular biology, immunotherapy and gene therapy.
- Serves as vice chief and director of institution’s Lung Research, Pulmonary, and Critical Care Medicine units.
- Research interest in cell and molecular biology.
- Seeking better understanding of the microenvironment in which tumors grow and novel ways to alter it to increase the effectiveness of immunotherapy.
- Exploring means of modifying T cells so that they can more easily attach to tumors, have greater killing power, and resist being neutralized by the tumor microenvironment.
- Participating in clinical trials using an inserted adenovirus in the pleural space and T cells altered to attack the mesothelioma tumor target.
- Authored or co-authored many articles in peer-reviewed journals.
- Teaches at University of Pennsylvania Perleman School of Medicine.
- Elected to American Society for Clinical Investigation.
- M.D. degree from University of Pennsylvania School of Medicine.